Atrial fibrillation pathophysiology: implications for management.
about
Biomarkers and the prediction of atrial fibrillation: state of the artThe Current Role of Omega-3 Fatty Acids in the Management of Atrial FibrillationAtrial Fibrillation and Fibrosis: Beyond the Cardiomyocyte Centric ViewWhat do we currently know about metabolic syndrome and atrial fibrillation?Inflammation and C-reactive protein in atrial fibrillation: cause or effect?Atrial Fibrillation: The Science behind Its DefianceAtrial fibrillation: review of current treatment strategiesCryoablation in persistent atrial fibrillation - a critical appraisalMapping Atrial Fibrillation: 2015 UpdateAtrial arrhythmias in inherited arrhythmogenic disordersEarly life predictors of atrial fibrillation-related mortality: evidence from the health and retirement studySinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation.Translational research in atrial fibrillation: a quest for mechanistically based diagnosis and therapy.Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and managementEffect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.Number of P-wave fragmentations on P-SAECG correlates with infiltrated atrial fatCardiac purinergic signalling in health and diseaseElectrical remodeling of preoptic GABAergic neurons involves the Kv1.5 subunit.Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults.Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.Long noncoding RNAs and novel inflammatory genes determined by RNA sequencing in human lymphocytes are up-regulated in permanent atrial fibrillation.A Potential Role of Esophageal Cancer Related Gene-4 for Atrial Fibrillation.Degradation of a connexin40 mutant linked to atrial fibrillation is accelerated.Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes.Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.Exploring susceptibility to atrial and ventricular arrhythmias resulting from remodeling of the passive electrical properties in the heart: a simulation approachConnexin40 abnormalities and atrial fibrillation in the human heartIncreased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillationCYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophyTASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation.Electrophysiological characteristics of paroxysmal atrial fibrillation originating from superior vena cava: a clinical analysis of 30 cases.Atrial fibrillation complicated by heart failure induces distinct remodeling of calcium cycling proteinsStructural heterogeneity modulates effective refractory period: a mechanism of focal arrhythmia initiationDrier air, lower temperatures, and triggering of paroxysmal atrial fibrillationAtrial Fibrillation: Biophysics, Molecular Mechanisms, and Novel TherapiesFibrosis in Atrial Fibrillation - Role of Reactive Species and MPO.Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing.
P2860
Q26739847-79B6827C-DBD3-4D7A-95E9-5F988F94121DQ26781534-1E703B3D-2E3D-4D0E-97F6-DC2564C3556FQ26800997-96078CC5-3D40-42A1-B5E6-6B50CDD331C0Q26864437-1F5A27F6-4268-4A70-885C-F15CAE0507C4Q26865381-618C50B4-4E50-42CB-A27A-34B7863F5EFAQ28072139-5989D3F7-3836-4DDC-A5C3-DBEE4E87810AQ28073181-76217173-45E5-4DA3-94FD-033BDDBE37CCQ28073718-479C015E-4975-4CCB-90A2-A6616F5511FCQ28075512-E075B03A-41A6-479C-B915-C5EE374BC9AFQ28076679-8D7562ED-FFD0-4170-A069-8503B5A98EE2Q28397562-D0AC6C28-F602-4A8C-AA4A-FCE8B1638EEBQ30238620-D90BA460-16C1-4BCF-9CB3-383BAA624C61Q30375302-0E6FD4DB-3519-4EFC-9364-B85E5361DF05Q30459988-B7B2C406-A129-470B-8170-2B3FAEE76056Q30531060-BC07300B-F97A-438D-93B8-BB1DD4DAA4AEQ30579851-48A31B0E-A1CE-4FBB-BD6D-0978CAF1D30CQ30772422-1151989E-5B30-42CE-83C4-18ACD0239B1AQ30775739-BEAAC131-7BC1-4BFD-B3EE-D7B68225645AQ33165093-273D4A19-55AA-424B-8298-A3585E08F783Q33568065-E6427B91-0345-4689-8EA5-03AD253EC0F1Q33609368-B960BCE0-2565-4279-9E98-AE9B7B3FCA5AQ33631895-BE85FE71-D318-44F7-935C-C5D849E4A332Q33733194-9E984C8F-B5A5-42D7-9462-823CDBD618E3Q33758744-D36F60AC-68DF-4E9B-99EB-4D0EA214A19FQ34055972-B7F39EED-6BC2-4325-844F-145B79CB6E48Q34297226-7C9D4F92-3A69-4C4A-9A67-22CF905F850DQ34388593-CE9CE03C-B7D7-47C4-9B66-B5512B59F97DQ34431833-B64063B9-952F-4F0F-A16F-3165D8781487Q34495974-B672A08C-9792-47D3-856B-068FB17744B8Q34604320-BFC22F63-9B33-4146-93B3-95BF8DBD04E6Q34611013-E7DDE9F2-A124-46C5-9CC1-8E6ACD481784Q34983743-B975C16F-9CFF-4953-AE1C-021B04F90EDEQ35115822-906F9966-4E61-42D4-8290-A88274BA7B98Q35173422-DFB4A07D-C130-4CF7-89CA-1A0C2B4F6ADCQ35180988-8D69CA41-803E-49AB-A8CC-C071F4C72919Q35309887-5731CA64-E5E3-4D27-9FD0-8885E24BA663Q35853709-CD8CE7D6-DA23-432B-8BDD-5309708EA40FQ35882442-4FFAB602-8201-41D2-9669-657C62310F07Q36047754-C235958F-9212-4A0D-A37D-7C31E5A35B41Q36061487-295117C1-033B-40C8-877C-1006766B4C0E
P2860
Atrial fibrillation pathophysiology: implications for management.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Atrial fibrillation pathophysiology: implications for management.
@en
Atrial fibrillation pathophysiology: implications for management.
@nl
type
label
Atrial fibrillation pathophysiology: implications for management.
@en
Atrial fibrillation pathophysiology: implications for management.
@nl
prefLabel
Atrial fibrillation pathophysiology: implications for management.
@en
Atrial fibrillation pathophysiology: implications for management.
@nl
P2093
P1433
P1476
Atrial fibrillation pathophysiology: implications for management
@en
P2093
Kunihiro Nishida
Takeshi Kato
Yu-ki Iwasaki
P304
P356
10.1161/CIRCULATIONAHA.111.019893
P407
P577
2011-11-01T00:00:00Z